Investor profile
Brandon Capital has backed 3 European tech companies across 4 funding rounds between 2022 and 2025, joining rounds totalling €197M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| NRG Therapeutics | UK | 2 | €76M |
| Pheon Therapeutics | UK | 1 | €71M |
| CatalYm | Germany | 1 | €50M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Pheon Therapeutics | Series A | €71M | 2022-09 |
| NRG Therapeutics | Series B | €58M | 2025-09 |
| CatalYm | Series C | €50M | 2022-11 |
| NRG Therapeutics |
| Series A |
| €18M |
| 2022-11 |
